This is Sponsored Content

We often assess facial skin diseases solely based on what we can see.
Is it time we looked beyond the visible?

The 2018 Beyond the Visible report provided new insights into rosacea and the burden associated with invisible symptoms. These insights further highlighted how little is really known of the burden faced by those suffering from facial skin diseases. The new 2020 report, Beyond the Visible: rosacea and psoriasis of the face, explores new dimensions of the burden faced by both rosacea and psoriasis of the face patients.

Contributing authors

  • Prof. Dr. Dr. Martin Steinhoff

    Chairman, Dept. of Dermatology, Director, Translational Research Institute, Hamad Medical Corporation, Will Cornell University Qatar, Qatar University, Qatar

  • Dr. Julie Harper

    Dermatologist at the Dermatology and Skin Care Center in Birmingham, USA

  • Prof. Dr. Uwe Gieler

    Dept. of Dermatology and Clinic of Psychosomatic Medicine and Psychotherapy Justus-Liebig-University of Giessen, Germany

  • Dr. Anthony Bewley

    Consultant Dermatologist, Barts Health, and Lecturer, Queen Mary College of Medicine, University of London, London, UK

  • Prof. Dr. Jerry Tan

    Adjunct Professor, Western University, Windsor, Ontario, Canada

Funding and support for the survey and report provided by Galderma.

Survey was conducted by Kantar Heath, with writing support provided by Havas Life Medicom.

SOO20-03-0086a/USMP/NON/0144/0420a Date of preparation: April 2020

© 2020 Galderma S.A. All Rights Reserved. All trademarks are the property of their respective owners.


Download Report

Asset 1


Download Report

Asset 1